MedTech Dive April 4, 2024
The company has pushed back its expected closing date for the acquisition due to the second request from the Federal Trade Commission.
Dive Brief:
- Boston Scientific received a second request for information on Wednesday from the Federal Trade Commission about its proposed $3.7 billion acquisition of Axonics.
- The request extends the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act until 30 days after both Boston Scientific and Axonics have complied, unless the waiting period is extended voluntarily by the companies or terminated earlier by the FTC.
- As a result, Boston Scientific now expects the merger to be completed in the second half of 2024, a delay from its initial target for closing the deal in the first half of...
Today's Sponsors
Today's Sponsor